Christopher M. Jewell, Chief Scientific Officer: Cartesian Therapeutics RNAC Planned sale · Filed 25/11/19

Trade details

Type: Planned sale notice
Stock: Cartesian Therapeutics RNAC
Person: Christopher M. JewellChief Scientific Officer
Planned sale date: 25/11/19
Filed: 25/11/19

0.1% of shares outstanding to be sold

Cartesian Therapeutics trades, last 26 weeks

What else happened in Cartesian Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/20~25/12/19

Christopher M. Jewell's recent trades

Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$68.9K
9,000 sh
$68.9K
Filed 01/13
Traded 01/13
Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$12.1K
1,510 sh
$12.1K
Filed 01/09
Traded 01/09
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.6K
1,286 sh
$21.6K
Filed 25/01/07
Traded 25/01/06
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.1K
1,264 sh
$21.1K
Filed 25/01/07
Traded 25/01/03
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$303.1K
18,550 sh
$303.1K
Filed 24/11/18
Traded 24/11/14